期刊文献+

CpG ODN作为黏膜免疫佐剂的研究进展 被引量:4

Advances in research on CpG oligodeoxynucleotides as mucosal immunomodulatory adjuvants
原文传递
导出
摘要 经黏膜免疫因其简便易行、可同时激发黏膜免疫和系统免疫应答等优点受到极大关注。但由于存在黏膜屏障,能有效介导黏膜免疫应答的佐剂已成为研究热点。在诸多在研佐剂中,CpG ODN具有极强的黏膜免疫激活作用,诱导以Th1型为主的免疫应答,具有广阔的应用前景,本文综述了CpG ODN作为黏膜免疫佐剂的研究进展。 Being user-friendly and efficient for initiating both the mucosal and systemic immunity, immunization through mucous membrane has played a more and more important role. To overcome the mucosal barrier, proper mucosal adjuvants are pivotal for stimulating mucosal immunity. CpG oligodeoxynucleotides can induce Th1 type immune response and possess the action of mucosal immune activation. In this paper the immune activation and the use of CpG ODN as mucosal adjuvant are reviewed.
出处 《军事医学科学院院刊》 CSCD 北大核心 2009年第1期91-94,共4页 Bulletin of the Academy of Military Medical Sciences
基金 国家“十一五”科技重大专项(2008zx10206)
关键词 CPG ODN 黏膜免疫 佐剂 CpG ODN mucosal immunity adjuvant
  • 相关文献

参考文献32

  • 1Vollmer J, Weeratna R, Payette P, et al. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities[ J]. Eur J Immunol,2004,34( 1 ) :251 -262.
  • 2Hacker G,Redecke V,Hacker H. Activation of the immune system by bacterial CpG-DNA [J]. Immunology, 2002, 105 ( 3 ) : 245 - 251.
  • 3Takeahita F, Gursel I, Ishhii K J, et al. Signal transduction pathway mediated by the interaction of CpG DNA with Toll-like receptor 9[J]. Semin Immunol,2004,16 ( 1 ) : 17 - 22.
  • 4Wagner M, Pocck H, Jahrsdoerfer B,etal. IL-12 p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA[J]. J Immunol,200d,172 (2) :954 - 963.
  • 5Gould MP, Greene JA, Bhoj V, et al. Distinct modulatory effects of LPS and CpG on IL-18-dependent IFN-gamma synthesis [ J]. J Immunol,2004,172 (3) : 1754 - 1762.
  • 6Sabena U, Lucy CF, John DC. Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens [ J]. Vaccine ,2007,25 (47) :7984 - 7993.
  • 7Moldoveanu Z, Love-Human L, Huang WQ,et al. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus[ J]. Vaccine, 1998,16 (11-12) : 1216 - 1224.
  • 8McCluskie MJ,Weeratna RD,Krieg AM,et al. CpG DNA is an effective oral adjuvant to protein antigens in mice [ J ]. Vaccine, 2000,19(7-8) :950-957.
  • 9郭桐生,冯强,郭刚,解庆华,邹全明.CpG基序对幽门螺杆菌疫苗的免疫佐剂效应实验研究[J].第三军医大学学报,2004,26(3):238-241. 被引量:1
  • 10Alignani D, Maletto B, Liscovsky M, et al. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice [ J ]. J LeukocBiol, 2005,77 (6) :898 -905.

二级参考文献87

共引文献30

同被引文献48

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部